Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010

Background. In the United States, measles, mumps, rubella, and varicella immunity is now primarily achieved through vaccination. Monitoring population immunity is necessary. Methods. We evaluated seroprevalence of antibodies to measles, mumps, rubella, and varicella using the National Health and Nut...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebo, Emmaculate J., Kruszon-Moran, Deanna M., Marin, Mona, Bellini, William J., Schmid, Scott, Bialek, Stephanie R., Wallace, Gregory S., McLean, Huong Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438887/
https://www.ncbi.nlm.nih.gov/pubmed/26034757
http://dx.doi.org/10.1093/ofid/ofv006
_version_ 1782372410380517376
author Lebo, Emmaculate J.
Kruszon-Moran, Deanna M.
Marin, Mona
Bellini, William J.
Schmid, Scott
Bialek, Stephanie R.
Wallace, Gregory S.
McLean, Huong Q.
author_facet Lebo, Emmaculate J.
Kruszon-Moran, Deanna M.
Marin, Mona
Bellini, William J.
Schmid, Scott
Bialek, Stephanie R.
Wallace, Gregory S.
McLean, Huong Q.
author_sort Lebo, Emmaculate J.
collection PubMed
description Background. In the United States, measles, mumps, rubella, and varicella immunity is now primarily achieved through vaccination. Monitoring population immunity is necessary. Methods. We evaluated seroprevalence of antibodies to measles, mumps, rubella, and varicella using the National Health and Nutrition Examination Survey during 2009–2010. Results. Measles, mumps, rubella, and varicella seroprevalence was 92.0% (95% confidence interval [CI], 90.9%−93.0%), 87.6% (CI, 85.8%−89.2%), 95.3% (CI, 94.3%−96.2%), and 97.8% (CI, 97.1%−98.3%), respectively. United States (US)-born persons had lower mumps seroprevalence and higher varicella seroprevalence than non-US born persons. Conclusions. Seroprevalence was high (88%–98%) for all 4 viruses in the US population during 2009−2010.
format Online
Article
Text
id pubmed-4438887
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-44388872015-06-01 Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010 Lebo, Emmaculate J. Kruszon-Moran, Deanna M. Marin, Mona Bellini, William J. Schmid, Scott Bialek, Stephanie R. Wallace, Gregory S. McLean, Huong Q. Open Forum Infect Dis Brief Reports Background. In the United States, measles, mumps, rubella, and varicella immunity is now primarily achieved through vaccination. Monitoring population immunity is necessary. Methods. We evaluated seroprevalence of antibodies to measles, mumps, rubella, and varicella using the National Health and Nutrition Examination Survey during 2009–2010. Results. Measles, mumps, rubella, and varicella seroprevalence was 92.0% (95% confidence interval [CI], 90.9%−93.0%), 87.6% (CI, 85.8%−89.2%), 95.3% (CI, 94.3%−96.2%), and 97.8% (CI, 97.1%−98.3%), respectively. United States (US)-born persons had lower mumps seroprevalence and higher varicella seroprevalence than non-US born persons. Conclusions. Seroprevalence was high (88%–98%) for all 4 viruses in the US population during 2009−2010. Oxford University Press 2015-01-20 /pmc/articles/PMC4438887/ /pubmed/26034757 http://dx.doi.org/10.1093/ofid/ofv006 Text en Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
spellingShingle Brief Reports
Lebo, Emmaculate J.
Kruszon-Moran, Deanna M.
Marin, Mona
Bellini, William J.
Schmid, Scott
Bialek, Stephanie R.
Wallace, Gregory S.
McLean, Huong Q.
Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010
title Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010
title_full Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010
title_fullStr Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010
title_full_unstemmed Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010
title_short Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010
title_sort seroprevalence of measles, mumps, rubella and varicella antibodies in the united states population, 2009–2010
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438887/
https://www.ncbi.nlm.nih.gov/pubmed/26034757
http://dx.doi.org/10.1093/ofid/ofv006
work_keys_str_mv AT leboemmaculatej seroprevalenceofmeaslesmumpsrubellaandvaricellaantibodiesintheunitedstatespopulation20092010
AT kruszonmorandeannam seroprevalenceofmeaslesmumpsrubellaandvaricellaantibodiesintheunitedstatespopulation20092010
AT marinmona seroprevalenceofmeaslesmumpsrubellaandvaricellaantibodiesintheunitedstatespopulation20092010
AT belliniwilliamj seroprevalenceofmeaslesmumpsrubellaandvaricellaantibodiesintheunitedstatespopulation20092010
AT schmidscott seroprevalenceofmeaslesmumpsrubellaandvaricellaantibodiesintheunitedstatespopulation20092010
AT bialekstephanier seroprevalenceofmeaslesmumpsrubellaandvaricellaantibodiesintheunitedstatespopulation20092010
AT wallacegregorys seroprevalenceofmeaslesmumpsrubellaandvaricellaantibodiesintheunitedstatespopulation20092010
AT mcleanhuongq seroprevalenceofmeaslesmumpsrubellaandvaricellaantibodiesintheunitedstatespopulation20092010

Ejemplares similares